The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Hofseth BioCare ASA (HBC) has officially released its Annual Report and Sustainability Report for the 2025 fiscal year. Alongside the financial results, the company disclosed that a previously announced private placement of NOK 158 million remains incomplete. The capital raise, which was first introduced in October 2025, has faced setbacks due to technical and legal complexities involving the lead investor. Despite these hurdles, the investor has reaffirmed their commitment to the transaction, with a revised completion date now expected in the second quarter of 2026. This delay introduces short-term liquidity uncertainty regarding the balance sheet, though the finalization of the annual report provides essential transparency for shareholders. The company continues to navigate these regulatory challenges while maintaining its operational focus within the biotech sector.
Sign up free to access this content
Create Free Account